Effectiveness and safety of ceftazidime-avibactam in Chinese patients with hospital-acquired pneumonia, including ventilator-associated pneumonia: A Phase 4, multi-centre, open-label study

Background: Ceftazidime-avibactam was approved in patients with hospital-acquired pneumonia (HAP), including ventilator-associated pneumonia (VAP), based on the multinational Phase 3 REPROVE study. This study assessed efficacy and safety of ceftazidime-avibactam in Chinese adults with HAP/VAP. Metho...

全面介紹

書目詳細資料

Principais autores:	Jinyi Yuan, Haihui Huang, Fei Guo, Aimin Li, NanYan Xu, Xiaoyue Chang, Zuke Xiao, Huiqing Zeng, Hua Qiao, Liangfa Tang, Yunsong Yu, Bin Liu, Panpan Wang, Paurus Irani, Rienk Pypstra, Junchao Lu, Fanglei Liu, Yuting Mu, Yingyuan Zhang
格式:	Artigo
語言:	Inglês
出版:	Elsevier 2025-06-01
叢編:	Journal of Global Antimicrobial Resistance
主題:	Gram-negative bacteria Clinical trial Antimicrobial therapy
在線閱讀:	http://www.sciencedirect.com/science/article/pii/S221371652500061X
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!